# MASSACHUSETTS INSTITUTE OF TECHNOLOGY: Targeting minimal residual disease in AML by using single-cell morphological and biophysical analysis with deep learning

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| Location | CAMBRIDGE, MA |
| Project | Targeting minimal residual disease in AML by using single-cell morphological and biophysical analysis with deep learning |
| Project number | 5U01CA282163-03 |
| Mechanism | U01 |
| Institute | National Cancer Institute |
| Award | $630,475 |
| Awarded | 2026-09-04 |
| Project period | 2024-09-09 to 2029-08-31 |
| UEI | E2NYLCDML6V1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11404887). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.